Endocrinologic and
Metabolic Drugs Advisory Committee and the
Drug Safety and Risk
Management Advisory Committee Meeting
July 30, 2007
SLIDES
Guest Speaker Presentation
Robert E. Ratner,
M.D., (ppt) (html)
Vice-President of
Scientific Affairs, MedStar Research Institute
GlaxoSmithKline Presentation
Ronald L. Krall, M.D.,
GlaxoSmithKline (pdf)
Murray
W. Stewart, D.M., F.R.C.P.,
GlaxoSmithKline (pdf)
Ronald L. Krall,
M.D., GlaxoSmithKline (pdf)
FDA Presentations
Joy D. Mele, M.S. (ppt) (html)
Karen M. Mahoney,
M.D. (ppt) (html)
Kate Gelperin, M.D.,
M.P.H. (ppt) (html)
David Graham, M.D.,
M.P.H. (ppt) (html)
NIH Speaker Presentation
David J. Gordon,
M.D., Ph.D. (ppt) (html)
Open Public Hearing
George A. Diamond,
M.D., F.A.C.C. and Sanjay Kaul, M.D., F.A.C.C., (ppt) (html)
Cedar-Sinai
Medical
Center
David Egilman, M.D.,
Brown
University
(ppt) (html)
Richard Hellman,
M.D., F.A.C.P., F.A.C.E., President, American
Association of Clinical Endocrinologists (ppt) (html)
Sidney Wolfe, M.D., Public Citizen’s
Health Research Group (ppt) (html)
Michael R. Peterson,
D.V.M, M.P.H., Dr.PH. and Thomas Bacon, Pharm.D, Office of Assistant
Secretary of Defense for Health Affairs/TRICARE (ppt) (html)
Samuel Nussbaum,
M.D., Executive Vice-President
and CMO, Wellpoint Inc (ppt) (html)
J. Rick Turner,
Ph.D., P.G.C.E. Chairman, Department
of Clinical Research,
Campbell
University
School
of Pharmacy, RTP Campus (ppt) (html)
Richard E. Ralston, Executive Director,
Americans for Free Choice in Medicine (pdf)
Up
| AC Home Page